Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil

被引:16
作者
Aczél, S [1 ]
Kurka, B [1 ]
Hering, S [1 ]
机构
[1] Inst Biochem Pharmacol, A-6020 Innsbruck, Austria
关键词
Ca2+ channels; mibefradil; use-dependent block; open state block; calcium channel inactivation;
D O I
10.1038/sj.bjp.0702092
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The action of mibefradil was studied on wild type class A calcium (Ca2+) channels and various class A/L-type channel chimaeras expressed in Xenopus oocytes. The mechanism of Ca2+ channel block by mibefradil was evaluated with two microelectrode voltage clamp. 2 Resting-state dependent block (or initial block) of barium currents (I-Ba) through class A Ca2+ channels was concentration dependent with an IC50 value of 208+/-23 mu M. 3 Mibefradil (50 mu M) did not significantly affect the midpoint voltage of the steady-state inactivation curve suggesting that inactivation does not promote Ca2+ channel block. Chimaeric class A/L-type Ca2+ channels inactivating with faster or slower kinetics than wild type class A channels were equally well inhibited by mibefradil as wild type class A channels. 4 Frequent Ca2+ channel activation facilitated I-Ba inhibition by mibefradil (use-dependent block). Recovery from use-dependent block was voltage-dependent. being slower at depolarized membrane potentials (tau = 75 +/- 15 s at -70 mV, (n = 6) vs tau = 20 +/- 2 s at - 100 mV, (n = 6), P<0.05). 5 We suggest that use-dependent block of class A Ca2+ channels by mibefradil occurs because of slow recovery from open channel block (SROB) and not because of drug binding to inactivated channels. 6 Voltage-dependent slow recovery from open state-dependent block provides a molecular basis for understanding the cardiovascular profile of mibefradil such as selectivity for vasculature and relative lack of negative inotropic effects.
引用
收藏
页码:447 / 454
页数:8
相关论文
共 31 条
  • [1] Extra- and intracellular action of quaternary devapamil on muscle L-type Ca2+-channels
    Berjukov, S
    Aczel, S
    Beyer, B
    Kimball, SD
    Dichtl, M
    Hering, S
    Striessnig, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (06) : 1197 - 1202
  • [2] Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967) - A new generation of calcium antagonists?
    Bernink, PJLM
    Prager, G
    Schelling, A
    Kobrin, I
    [J]. HYPERTENSION, 1996, 27 (03) : 426 - 432
  • [3] BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540
  • [4] Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: A multicenter placebo-controlled study
    Braun, S
    vanderWall, EE
    Emanuelsson, H
    Kobrin, I
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (02) : 317 - 322
  • [5] EFFECTS OF RO-40-5967, A NOVEL CALCIUM-ANTAGONIST, ON MYOCARDIAL-FUNCTION DURING ISCHEMIA INDUCED BY LOWERING CORONARY PERFUSION-PRESSURE IN DOGS - COMPARISON WITH VERAPAMIL
    CLOZEL, JP
    BANKEN, L
    OSTERRIEDER, W
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 (05) : 713 - 721
  • [6] Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site
    Degtiar, VE
    Aczel, S
    Doring, F
    Timin, EN
    Berjukow, S
    Kimball, D
    Mitterdorfer, J
    Hering, S
    [J]. BIOPHYSICAL JOURNAL, 1997, 73 (01) : 157 - 167
  • [7] Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha(1A)
    Doring, F
    Degtiar, VE
    Grabner, M
    Striessnig, J
    Hering, S
    Glossmann, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (20) : 11745 - 11749
  • [8] SEQUENCE AND EXPRESSION OF MESSENGER-RNAS ENCODING THE ALPHA-1-SUBUNIT AND ALPHA-2-SUBUNIT OF A DHP-SENSITIVE CALCIUM-CHANNEL
    ELLIS, SB
    WILLIAMS, ME
    WAYS, NR
    BRENNER, R
    SHARP, AH
    LEUNG, AT
    CAMPBELL, KP
    MCKENNA, E
    KOCH, WJ
    HUI, A
    SCHWARTZ, A
    HARPOLD, MM
    [J]. SCIENCE, 1988, 241 (4873) : 1661 - 1664
  • [9] FANG LM, 1991, EUR J PHARMACOL, V196, P205
  • [10] Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels
    Grabner, M
    Wang, ZY
    Hering, S
    Striessnig, J
    Glossmann, H
    [J]. NEURON, 1996, 16 (01) : 207 - 218